These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 9815243
1. In vitro antiviral susceptibilities of isolates from cytomegalovirus retinitis patients receiving first- or second-line cidofovir therapy: relationship to clinical outcome. Cherrington JM, Fuller MD, Lamy PD, Miner R, Lalezari JP, Nuessle S, Drew WL. J Infect Dis; 1998 Dec; 178(6):1821-5. PubMed ID: 9815243 [Abstract] [Full Text] [Related]
4. Cidofovir: a review of its use in cytomegalovirus retinitis in patients with AIDS. Plosker GL, Noble S. Drugs; 1999 Aug; 58(2):325-45. PubMed ID: 10473024 [Abstract] [Full Text] [Related]
6. Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Smith IL, Taskintuna I, Rahhal FM, Powell HC, Ai E, Mueller AJ, Spector SA, Freeman WR. Arch Ophthalmol; 1998 Feb; 116(2):178-85. PubMed ID: 9488269 [Abstract] [Full Text] [Related]
7. Cidofovir in the treatment of cytomegalovirus (CMV) retinitis. Garcia CR, Torriani FJ, Freeman WR. Ocul Immunol Inflamm; 1998 Sep; 6(3):195-203. PubMed ID: 9785611 [No Abstract] [Full Text] [Related]
8. A deletion mutation in region V of the cytomegalovirus DNA polymerase sequence confers multidrug resistance. Chou S, Miner RC, Drew WL. J Infect Dis; 2000 Dec; 182(6):1765-8. PubMed ID: 11069251 [Abstract] [Full Text] [Related]
9. Case report: persistent cytomegalovirus (CMV) infection after haploidentical hematopoietic stem cell transplantation using in vivo alemtuzumab: emergence of resistant CMV due to mutations in the UL97 and UL54 genes. Oshima K, Kanda Y, Kako S, Asano-Mori Y, Watanabe T, Motokura T, Chiba S, Shiraki K, Kurokawa M. J Med Virol; 2008 Oct; 80(10):1769-75. PubMed ID: 18712833 [Abstract] [Full Text] [Related]
15. Randomized, controlled study of the safety and efficacy of intravenous cidofovir for the treatment of relapsing cytomegalovirus retinitis in patients with AIDS. Lalezari JP, Holland GN, Kramer F, McKinley GF, Kemper CA, Ives DV, Nelson R, Hardy WD, Kuppermann BD, Northfelt DW, Youle M, Johnson M, Lewis RA, Weinberg DV, Simon GL, Wolitz RA, Ruby AE, Stagg RJ, Jaffe HS. J Acquir Immune Defic Syndr Hum Retrovirol; 1998 Apr 01; 17(4):339-44. PubMed ID: 9525435 [Abstract] [Full Text] [Related]
18. Cytomegalovirus retinitis and viral resistance. Prevalence of resistance at diagnosis, 1994. Cytomegalovirus Retinitis and Viral Resistance Study Group. Jabs DA, Dunn JP, Enger C, Forman M, Bressler N, Charache P. Arch Ophthalmol; 1996 Jul 01; 114(7):809-14. PubMed ID: 8660163 [Abstract] [Full Text] [Related]
19. Ganciclovir-resistant cytomegalovirus (CMV) retinitis in a patient with wild-type CMV in her plasma. Moss HB, Chavala S, Say E, Miller MB. J Clin Microbiol; 2012 May 01; 50(5):1796-9. PubMed ID: 22337988 [Abstract] [Full Text] [Related]
20. Evolution of mutations conferring multidrug resistance during prophylaxis and therapy for cytomegalovirus disease. Chou S, Marousek G, Guentzel S, Follansbee SE, Poscher ME, Lalezari JP, Miner RC, Drew WL. J Infect Dis; 1997 Sep 01; 176(3):786-9. PubMed ID: 9291334 [Abstract] [Full Text] [Related] Page: [Next] [New Search]